(MENAFN- GlobeNewsWire - Nasdaq) Nanoparticle technology offers significant opportunities in pharma and biomedicine, particularly in drug delivery, diagnostics, and therapeutic innovations. With applications in advanced imaging, targeted drug delivery, and novel therapies, the field is poised to reshape modern medicine, addressing solubility, efficacy, and safety challenges.

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Nov 12th - Nov 13th, 2025)" has been added to ResearchAndMarkets's offering.

This course offers an in-depth exploration of the rapidly evolving field of nanoparticle technology and its transformative applications in the pharmaceutical and biomedical industries.

Due to their ability to interact with biological systems at the molecular level, nanoparticles have emerged as powerful tools in drug delivery, diagnostics, and therapeutic innovations. From improving drug solubility and targeted delivery to enabling advanced imaging techniques, nanoparticles are reshaping modern medicine.

Participants will explore the different types of nanoparticles, including liposomes, polymeric nanoparticles, and metallic nanoparticles, and their specific applications in pharmaceutical, medtech and biotech Industries.

The course will delve into nanoparticle design, synthesis, and functionalisation and the regulatory and safety considerations involved in their use. Attendees will also examine cutting-edge research and real-world case studies on how nanoparticles enhance drug efficacy, minimise side effects, and develop novel therapeutic solutions.

Benefits of attending

• Gain an introduction to nanoparticles: types, properties and biomedical relevance
• Understand nanoparticles in drug delivery: improving solubility, stability and targeting
• Learn different applications of nanoparticles in diagnostics and imaging
• Explore nanoparticles in controlled and sustained drug release
• Discuss regulatory and safety considerations for nanoparticle-based pharmaceuticals
• Delve into applications in gene therapy, cancer treatment, and regenerative medicine
• See case studies on successful nanoparticle-based drugs and therapies
• Discover future trends and innovations in nanoparticle research and development

Certifications:

• CPD: 12 hours for your records
• Certificate of completion

Who Should Attend:

This course is designed for professionals involved in pharmaceutical development, biomedical research and medical innovation, including:

• Pharmaceutical scientists and researchers
• Biomedical engineers and researchers
• Drug development professionals
• Regulatory affairs specialists in pharma and biotech
• Nanotechnology researchers and engineers
• Clinical researchers and medical scientists
• R&D managers in the pharmaceutical and biotech industries
• Consultants and advisors in pharmaceutical innovation and nanomedicine

This course is ideal for professionals looking to deepen their understanding of nanoparticle technology, explore its vast potential in drug and therapeutic development and stay at the forefront of pharmaceutical and biomedical advancements.

Course Agenda:

Overview of nanotechnology

• Introduction to nanotechnology: brief history, definition and significance
• Nanotechnology vs. nanoscience: key differences and their implications in pharmaceutical and biomedical contexts
• Basic nanoparticle concepts: size, shape, surface area and surface charge
• Nanoparticle types: organic (liposomes, dendrimers), inorganic (gold, silver, silica) and hybrid nanoparticles

Nanoparticle characterisation

• Size and shape characterisation: techniques like Dynamic Light Scattering (DLS), Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM)
• Surface properties: Zeta potential, surface charge and hydrophobicity/hydrophilicity
• Stability and encapsulation efficiency: methods for assessing nanoparticle stability and drug loading efficiency

Nanoparticles in drug delivery

• Mechanisms of nanoparticle-based drug delivery: passive targeting (size and EPR effect) vs. active targeting (surface modifications for receptor-mediated targeting)
• Controlled and sustained release: nanoparticles for controlled release, bioavailability enhancement and targeted delivery
• Challenges and opportunities in drug delivery: overcoming biological barriers, such as the blood-brain barrier, immune system evasion and toxicological concerns

Pharmaceutical applications of nanoparticles

• Nanoparticles for oral drug delivery: enhanced solubility, bioavailability and controlled release
• Injectable nanoparticle systems: liposomes, micelles and polymeric nanoparticles for intravenous drug administration
• Nanoparticles in vaccine delivery: their role in antigen delivery, immune response modulation and vaccine adjuvants

Nanoparticles in cancer therapy

• Nanoparticle-based cancer therapy: active vs. passive targeting in tumours.
• Therapeutic applications: chemotherapy, photothermal therapy, gene therapy and RNA delivery using nanoparticles
• Nanoparticle-drug conjugates: targeted delivery of cytotoxic drugs and antibodies

Nanoparticles in diagnostic and imaging techniques

• Nanoparticles in imaging: role in MRI, CT, fluorescence, and PET imaging
• Biosensors and diagnostics: using nanoparticles for early detection of diseases through biosensing technologies
• Nanoparticles for targeted imaging: surface modifications for specific tissue or disease targeting

Biocompatibility, toxicity and regulatory challenges

• Biocompatibility of nanoparticles: understanding cellular interactions, immune system activation and tissue penetration
• Nanotoxicology: safety concerns regarding nanoparticles in the human body (cytotoxicity, oxidative stress and inflammation)
• Regulatory considerations: current guidelines for nanoparticle-based drug products, challenges in regulatory approval and standardisation

Future directions and emerging trends

• Nanomedicine and personalised medicine: the role of nanoparticles in tailored therapies
• Nanoparticles in RNA and gene delivery: current advances in CRISPR/Cas9 delivery and mRNA therapeutics
• Sustainability and ethical concerns: biodegradable nanoparticles, environmental impact and ethical considerations in the biomedical use of nanomaterials

For more information about this training visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN16102025004107003653ID1110204320